MAPS founder Rick Doblin views the partnership as a symbolic bridge between psychedelics and mindfulness, which have long been separated by an ideological schism.
Eating disorders are among the deadliest of mental illnesses, and established treatments are limited in their efficacy. Research shows that psychedelics might help.
They will survey people’s experiences before and after taking magic mushrooms, an approach Roland Griffiths calls a “huge advance forward.”
As global interest in Dutch retreats grows, psilocybin truffle guides and groups have come together to establish self-regulation and best practices for those who offer guided tripping.
A new study investigating ayahuasca’s effects when taken within Shipibo-style ceremonies finds a significant decrease in neuroticism.
Researcher and professor Dr. Charles Grob discusses The Lundquist Institute’s announcement of a new multi-site clinical trial examining psilocybin for palliative care, the first study of its kind since the 1960’s, in this Q & A with Lucid News.
A newly published review calls for more research into psilocybin’s potential to treat obsessive-compulsive disorder (OCD) based on promising findings and anecdotal reports.
LSD use in American adults rose over 50 percent between 2015 and 2018, a surge that one researcher attributes to rising national chaos.
A network of psychedelic healthcare providers offers a comprehensive global directory of psychedelic clinical trials that are actively enrolling.
A group of Canadian researchers proposes clear guidelines for academic researchers to keep the field of psychedelic science transparent.